Cagrilintide - 5 mg

RESEARCH USE ONLY NOT FOR HUMAN CONSUMPTION

Cagrilintide 5 mg — Research Use Only

Cagrilintide is a long-acting investigational amylin analogue/amylin receptor agonist being studied in metabolic and endocrine research. Amylin is a naturally occurring pancreatic hormone involved in physiological pathways associated with nutrient intake, satiety, gastric function, glucose regulation, and energy balance.

Cagrilintide has received significant research attention both as an individual investigational compound and in combination with the GLP-1 receptor agonist semaglutide, a combination known as CagriSema. Clinical research programs have investigated cagrilintide-related pathways in areas including body-weight regulation, appetite and satiety signaling, glucose metabolism, and metabolic health.

RESEARCH DETAILS

Cagrilintide 5 mg — Research Use Only

Cagrilintide is a long-acting investigational amylin analogue/amylin receptor agonist being studied in metabolic and endocrine research. Amylin is a naturally occurring pancreatic hormone involved in physiological pathways associated with nutrient intake, satiety, gastric function, glucose regulation, and energy balance.

Cagrilintide has received significant research attention both as an individual investigational compound and in combination with the GLP-1 receptor agonist semaglutide, a combination known as CagriSema. Clinical research programs have investigated cagrilintide-related pathways in areas including body-weight regulation, appetite and satiety signaling, glucose metabolism, and metabolic health.

Research Areas of Interest

Cagrilintide may be of interest for laboratory and scientific investigation involving:

  • Amylin receptor signaling
  • Appetite and satiety pathways
  • Energy-balance mechanisms
  • Metabolic signaling
  • Glucose-regulation pathways
  • Body-weight regulation research
  • Amylin and GLP-1 pathway interactions

Cagrilintide monotherapy has progressed into Phase 3 research. Novo Nordisk reported that cagrilintide 2.4 mg produced an average 11.8% body-weight reduction versus 2.3% with placebo at 68 weeks under a trial estimand assuming participants remained on treatment; gastrointestinal adverse events reported in the research included nausea, vomiting, diarrhea, and constipation and were mainly transient and mild-to-moderate. These clinical findings describe the investigational pharmaceutical compound and should not be interpreted as establishing the safety, efficacy, or appropriate use of research material sold by PepperPep.com.

Product: Cagrilintide
Quantity: 5 mg
Form: Lyophilized research material
Category: Research compound
Intended Use: Laboratory and analytical research only

Important Research Use Notice

FOR RESEARCH USE ONLY. NOT FOR HUMAN OR VETERINARY USE OR CONSUMPTION.

This product is intended exclusively for legitimate laboratory, analytical, and scientific research. It is not a drug, dietary supplement, food, cosmetic, or medical product and is not offered for the diagnosis, treatment, cure, mitigation, or prevention of any disease or medical condition.

This product is not intended for human consumption, self-administration, compounding, or therapeutic use. Information provided by Pepper Health Products LLC dba PepperPep.com is supplied for research and educational reference purposes and does not constitute medical advice, dosing guidance, or instructions for human administration.

RESEARCH USE ONLY — NOT FOR HUMAN CONSUMPTION

All products and information provided on this website are intended for laboratory research purposes only. These products are not intended for human consumption and are not intended to diagnose, treat, cure, or prevent any disease.

AGE & RESEARCH USE CONFIRMATION

Peptides sold on this website are for

RESEARCH USE ONLY and NOT FOR HUMAN CONSUMPTION

By entering this website, you confirm that you are at least 21 years of age and that you are a qualified research professional. You acknowledge that the products purchased are for laboratory research purposes only and will not be used for human consumption.

Please confirm: